Implementing TearLab

"TearLab overall has led to the quality and image of our practice that we are very proactive in identifying problems where we can take care of them and give our patients the best possible clinical outcomes."

Doug Devries, OD - Eye Care Associates of Nevada

Image

Testing

The Decision to Incorporate Osmolarity Testing

"Our practice was looking for a progressive, quantitative method to diagnose and follow the progression of DED. Tear osmolarity testing offered a solution to both of these needs"

Roberto Conte - Business Manager at Eye Doctors of Washington

Implementing TearLab in Your Surgical Practice
OF
 

successful adoption

How point-of-care testing can grow your contact lens practice by aiding in lens selection, treatment recommendations and patient education.

“Osmolarity testing allows us to catch early patients at risk of dry eye, fit patients in lenses that they’re most likely to wear with success, and set appropriate expectations. It shows the need to address contact lens fitting from a proper and essential clinical perspective, and differentiates you from the “800 Contact Lens” competition.”

“If osmolarity reveals that there’s a barrier to successful wear, we treat it first, so we have the best chance of keeping the patient happy in their lenses. The osmolarity score also aids in setting realistic expectations with a multifocal lens. When patients know that their osmolarity score is too high, they’re less likely to conclude that multifocal contact lenses—or worse, your clinical skills—are to blame.”

Paul Karpecki, OD and Ian Benjamin Gaddie, OD

How osmolarity testing can help guide contact lens selection and make patients feel good about choosing healthier options—even when they cost more.

“Osmolarity testing allows you to justify your clinical decision-making in a way that patients can easily understand. When this quick test shows that osmolarity is high, it opens the door to a conversation about why trying something new is in the patient’s best interest.”

David Geffen, OD and Paul Karpecki, OD

Osmolarity testing allows you to justify your clinical decision-making in a way that patients can easily understand. When this quick test shows that osmolarity is high, it opens the door to a conversation about why trying something new is in the patient’s best interest.

“If this test leads you to properly diagnose ocular surface disease and prevent contact lens dropout, the economic return potential is significant.”

“Osmolarity testing also helps you manage dry eye more efficiently because, even though symptoms are usually the last thing to improve, improvement in osmolarity scores offers piece of mind that the patient is on the right path.”

John Rumpakis, OD, MBA, and Paul Karpecki, OD

U.S. reimbursement

TearLab is a laboratory test.

The TearLab Osmolarity System is an in vitro laboratory device and, as such, testing for Medicare patients is billed under the Clinical Laboratory Fee Schedule. Unlike the Physician Fee Schedule, Medicare patient co-payments or deductibles do not apply to services billed under the laboratory fee schedule, covered services are 100% reimbursed.

More on reimbursement Reimbursement FAQs

*CPT is a copyright and registered trademark of the American Medical Association (AMA).

What is CPT* Code 83861?

83861, Microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarity.

What fee schedule is 83861 paid from?

83861 is paid from the Medicare Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule.

Is Tearlab's Tear Osmolarity Test described in 83861?

Yes.

reimbursement canada

TearLab is a laboratory test.

The TearLab Osmolarity System is an in vitro laboratory device and, as such, testing for Medicare patients is billed under the Clinical Laboratory Fee Schedule. Unlike the Physician Fee Schedule, Medicare patient co-payments or deductibles do not apply to services billed under the laboratory fee schedule, covered services are 100% reimbursed.

More on reimbursement Reimbursement FAQs

*CPT is a copyright and registered trademark of the American Medical Association (AMA).

What is CPT* Code 83861?

83861, Microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarity.

What fee schedule is 83861 paid from?

83861 is paid from the Medicare Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule.

Is Tearlab's Tear Osmolarity Test described in 83861?

Yes.

reimbursement rest of the world

TearLab is a laboratory test.

The TearLab Osmolarity System is an in vitro laboratory device and, as such, testing for Medicare patients is billed under the Clinical Laboratory Fee Schedule. Unlike the Physician Fee Schedule, Medicare patient co-payments or deductibles do not apply to services billed under the laboratory fee schedule, covered services are 100% reimbursed.

More on reimbursement Reimbursement FAQs

*CPT is a copyright and registered trademark of the American Medical Association (AMA).

What is CPT* Code 83861?

83861, Microfluidic analysis utilizing an integrated collection and analysis device, tear osmolarity.

What fee schedule is 83861 paid from?

83861 is paid from the Medicare Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule.

Is Tearlab's Tear Osmolarity Test described in 83861?

Yes.

Contact Image

Contact Us

Please reach out and we'll get your question to the right person at TearLab!

Send a message

To Top